Department of Justice February 14, 2005 – Federal Register Recent Federal Regulation Documents
Results 1 - 3 of 3
Schedules of Controlled Substances: Placement of Zopiclone Into Schedule IV
This proposed rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance zopiclone, including its salts, isomers and salts of isomers into Schedule IV of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from the Acting Assistant Secretary for Health of the Department of Health and Human Services (DHHS) and on an evaluation of the relevant data by DEA. If finalized, this action will impose the regulatory controls and criminal sanctions of Schedule IV on those who handle zopiclone and products containing zopiclone.
Privacy Act of 1974; Systems of Records
Pursuant to the Privacy Act of 1974 (5 U.S.C. 552a), and Office of Management and Budget (OMB) Circular No. A-130, notice is hereby given that the Department of Justice, Federal Bureau of Investigation (FBI), is modifying the following systems of records: Bureau Mailing Lists, Justice/FBI-003 (previously published on June 22, 2001 at 66 FR 33560); Electronic Surveillance (ELSUR) Indices, Justice/FBI-006 (previously published on June 22, 2001 at 66 FR 33560); Security Access Control System (SACS), Justice/FBI-013 (previously published on October 3, 1993 at 58 FR 51877); and Blanket Routine Uses (BRU) Applicable to More Than One FBI Privacy Act System of Records, Justice/FBI-BRU (previously published on June 22, 2001 at 66 FR 33558). Opportunity for Comment: The Privacy Act (5 U.S.C. 552a(e)(4) and (11)) requires that the public be given 30 days in which to comment on any new or amended uses of information in a system of records. In addition, in accordance with Privacy Act requirements (5 U.S.C. 552a(r)), the Department of Justice has provided a report on these modifications to OMB and the Congress. OMB, which has oversight responsibilities under the Act, requires that OMB and the Congress be given 40 days in which to review major changes to Privacy Act systems. Therefore, the public, OMB, and the Congress are invited to submit written comments on this modification. Address Comments or Requests for Further Information to: Mary E. Cahill, Management Analyst, Management and Planning Staff, Justice Management Division, Department of Justice, 1400 National Place, Washington, DC 20530.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
